title: Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
authors.affiliation: Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, Canada.
authors.forename: H G
authors.initials: HG
authors.lastname: Klingemann
authors.forename: J D
authors.initials: JD
authors.lastname: Shepherd
authors.forename: D E
authors.initials: DE
authors.lastname: Reece
authors.forename: M J
authors.initials: MJ
authors.lastname: Barnett
authors.forename: S H
authors.initials: SH
authors.lastname: Nantel
authors.forename: H J
authors.initials: HJ
authors.lastname: Sutherland
authors.forename: J J
authors.initials: JJ
authors.lastname: Spinelli
authors.forename: G L
authors.initials: GL
authors.lastname: Phillips
mesh_terms: D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000379:methods / Q000401:mortality; D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D002330:Carmustine / Q000009:adverse effects; D017321:Clinical Trials, Phase I as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003556:Cystitis / Q000139:chemically induced; D005260:Female; D006504:Hepatic Veno-Occlusive Disease / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D015994:Incidence; D007951:Leukemia, Myeloid / Q000628:therapy; D008099:Liver / Q000187:drug effects / Q000528:radiation effects; D017563:Lung Diseases, Interstitial / Q000139:chemically induced / Q000453:epidemiology; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D012189:Retrospective Studies; D012307:Risk Factors; D014916:Whole-Body Irradiation / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D016190:Carboplatin; D002066:Busulfan; D002330:Carmustine; D008727:Methotrexate